2024 ICD-10-CM Diagnosis Code B37

by

Candidiasis

  • B37 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2024 edition of ICD-10-CM B37 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B37 – other international versions of ICD-10 B37 may differ.

Type 1 Excludes

  • neonatal candidiasis (P37.5)

Includes

  • candidosis
  • moniliasis

The following code(s) above B37 contain annotation back-references

 that may be applicable to B37:

  • A00-B99  Certain infectious and parasitic diseases
  • B35-B49  Mycoses

Clinical Information

  • A condition in which candida albicans, a type of yeast, grows out of control in moist skin areas of the body. It is usually a result of a weakened immune system, but can be a side effect of chemotherapy or treatment with antibiotics. Thrush usually affects the mouth (oral thrush); however, rarely, it spreads throughout the entire body.
  • Infection with a fungus of the genus candida. It is usually a superficial infection of the moist areas of the body and is generally caused by candida albicans. (Dorland, 27th ed)
  • Infection with a fungus of the genus candida; usually a superficial infection of the moist areas of the body and is generally caused by candida albicans; includes chronic mucocutaneous candidiasis, cutaneous candidiasis, oral candidiasis (thrush), and monilial vaginitis.

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change